202 related articles for article (PubMed ID: 28009087)
1. Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy.
Koga S; Sanchez-Contreras M; Josephs KA; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Wszolek ZK; Rademakers R; Dickson DW
Mov Disord; 2017 Feb; 32(2):246-255. PubMed ID: 28009087
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy.
Yokota O; Davidson Y; Bigio EH; Ishizu H; Terada S; Arai T; Hasegawa M; Akiyama H; Sikkink S; Pickering-Brown S; Mann DM
Acta Neuropathol; 2010 Jul; 120(1):55-66. PubMed ID: 20512649
[TBL] [Abstract][Full Text] [Related]
3. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
[TBL] [Abstract][Full Text] [Related]
4. Copathology in Progressive Supranuclear Palsy: Does It Matter?
Jecmenica Lukic M; Kurz C; Respondek G; Grau-Rivera O; Compta Y; Gelpi E; Troakes C; ; van Swieten JC; Giese A; Roeber S; Arzberger T; Höglinger G
Mov Disord; 2020 Jun; 35(6):984-993. PubMed ID: 32125724
[TBL] [Abstract][Full Text] [Related]
5. Old age amyotrophic lateral sclerosis and limbic TDP-43 pathology.
Murakami A; Koga S; Sekiya H; Oskarsson B; Boylan K; Petrucelli L; Josephs KA; Dickson DW
Brain Pathol; 2022 Nov; 32(6):e13100. PubMed ID: 35715944
[TBL] [Abstract][Full Text] [Related]
6. FTLD-TDP and progressive supranuclear palsy in comorbidity-a report of two cases with different clinical presentations.
Storey K; Johanidesová S; Matěj R; Keller J; Rohan Z; Rusina R
Neurocase; 2017 Feb; 23(1):5-11. PubMed ID: 27915581
[TBL] [Abstract][Full Text] [Related]
7. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
[TBL] [Abstract][Full Text] [Related]
8. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
[TBL] [Abstract][Full Text] [Related]
9. Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report.
Fujita K; Matsubara T; Miyamoto R; Sumikura H; Takeuchi T; Maruyama Saladini K; Kawarai T; Nodera H; Udaka F; Kume K; Morino H; Kawakami H; Hasegawa M; Kaji R; Murayama S; Izumi Y
BMC Neurol; 2019 Jul; 19(1):168. PubMed ID: 31319800
[TBL] [Abstract][Full Text] [Related]
10. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
11. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
[TBL] [Abstract][Full Text] [Related]
12. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and α-synuclein in glial cytoplasmic inclusions.
Koga S; Lin WL; Walton RL; Ross OA; Dickson DW
Neuropathol Appl Neurobiol; 2018 Dec; 44(7):707-721. PubMed ID: 29660838
[TBL] [Abstract][Full Text] [Related]
13. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.
Huin V; Deramecourt V; Caparros-Lefebvre D; Maurage CA; Duyckaerts C; Kovari E; Pasquier F; Buée-Scherrer V; Labreuche J; Behal H; Buée L; Dhaenens CM; Sablonnière B
Mov Disord; 2016 Dec; 31(12):1883-1890. PubMed ID: 27709663
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic basis of frontotemporal dementia in progressive supranuclear palsy.
Sakae N; Josephs KA; Litvan I; Murray ME; Duara R; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
Mov Disord; 2019 Nov; 34(11):1655-1662. PubMed ID: 31433871
[TBL] [Abstract][Full Text] [Related]
15. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
Yoshida K; Hata Y; Kinoshita K; Takashima S; Tanaka K; Nishida N
Acta Neuropathol; 2017 May; 133(5):809-823. PubMed ID: 28064358
[TBL] [Abstract][Full Text] [Related]
16. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
17. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
Front Neurol; 2020; 11():574. PubMed ID: 32754109
[No Abstract] [Full Text] [Related]
18. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.
Stutzbach LD; Xie SX; Naj AC; Albin R; Gilman S; ; Lee VM; Trojanowski JQ; Devlin B; Schellenberg GD
Acta Neuropathol Commun; 2013 Jul; 1():31. PubMed ID: 24252572
[TBL] [Abstract][Full Text] [Related]
19. Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies.
Cykowski MD; Arumanayagam AS; Powell SZ; Rivera AL; Abner EL; Roman GC; Masdeu JC; Nelson PT
Acta Neuropathol; 2022 May; 143(5):531-545. PubMed ID: 35366087
[TBL] [Abstract][Full Text] [Related]
20. Incidence and morphology of secondary TDP-43 proteinopathies: Part 1.
Acewicz A; Stępień T; Felczak P; Tarka S; Wierzba-Bobrowicz T
Folia Neuropathol; 2022; 60(3):267-276. PubMed ID: 36382478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
